共 50 条
Teriflunomide real-world outcomes in the phase 4 Teri-PRO Study: Results from Europe, Canada, and Latin America
被引:0
|作者:
Gold, R.
[1
]
Khatri, B.
[2
]
Edwards, K. R.
[3
]
Cavalier, S.
[4
]
Rufi, P.
[5
]
Thangavelu, K.
[4
]
Benamor, M.
[5
]
Coyle, P. K.
[6
]
机构:
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Wheaton Franciscan Healthcare, Reg MS Ctr, Ctr Neurol Disorders, Milwaukee, WI USA
[3] Multiple Sclerosis Ctr Northeastern New York, Latham, NY USA
[4] Sanofi Genzyme, Cambridge, MA USA
[5] Sanofi Genzyme, Chilly Mazarin, France
[6] SUNY Stony Brook, Stony Brook, NY 11794 USA
关键词:
D O I:
暂无
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
EP1145
引用
收藏
页码:197 / 197
页数:1
相关论文